BCAT2 and Global developmental delay: To date, BCAT2 human mutations have been reported in only six individuals, associated mainly with developmental delay and autistic features.39 Affected individuals displayed elevated plasma BCAA levels of up to 4 mmol/L (valine), with plasma BCKA levels remaining unchanged as in Bcat2p.Q300*/p.Q300* mice.